Futura Medical plc Board Appointment
Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, is pleased to announce that Andrew Unitt is being appointed to the Board as a non-executive director with effect from 1 January 2022. Andrew will replace Jonathan Freeman who will be stepping down as senior independent non-executive director on the 31 of December 2021.
